In vitro evaluation of drug susceptibilities of Babesia divergens isolates

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 818-820

  Brasseur, Philippe ^a   Lecoublet, Sophie ^a   Kapel, Nathalie ^b   Favennec, Loic ^a   Ballet, Jean J ^c  

^a HÔPITAL CHARLES NICOLLE   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c CHU Clemenceau   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBESIA; CHLOROQUINE; CLINDAMYCIN; IMIDOCARB; LINCOCINE; LINCOMYCIN; MEFLOQUINE; OXOMEMAZINE; OXOPIVERDINE; PENTAMIDINE ISETHIONATE; PHENAMIDINE; QUININE; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BABESIA; BABESIOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031956287     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.818     Document Type: Article

References (17)

1. Bayle, J., H. Dumon, J. J. Verdot, and R. Muratore. 1979. Human piroplasmosis. One case. Presse Med. 8:3674.
2. Beck, P., A. Gorenflot, J. P. Estebe, A. Marchand, and A. Roquilly. 1987. Insuffisance respiratoire aigüe d'un cas de babésiose humaine. Bull. Soc. Fr. Parasitol. 5:16.
3. Brasseur, P., S. Lecoublet, N. Kapel, L. Favennec, and J. J. Ballet. 1996. Quinine in the treatment of Babesia divergens infections in humans. Eur. J. Clin. Microbiol. Infect. Dis. 15:840-541.
4. Brockelman, C. R., and P. Tan-Ariya. 1991. Development of an in vitro microtest to assess drug susceptibility of Babesia bovis and Babesia bigemina. J. Parasitol. 77:994-997.
5. Entrican, J. H., H. Williams, I. A. Cook, W. M. Lancaster, J. C. Clark, and L. P. Joyner. 1979. Babesiosis in man: report of a case from Scotland with observations on the infecting strain. J. Infect. 1:227-234.
6. Gorenflot, A., P. Brasseur, G. Bonmarchand, D. Laneele, and D. Simonin. 1988. Two cases of severe human babesiosis treated with success. Presse Med. 19:335.
7. Gorenflot, A., P. Brasseur, E. Precigout, M. L'Hostis, A. Marchand, and J. Schrevel. 1991. Cytological and immunological responses to Babesia divergens in different hosts: ox, gerbil, man. Parasitol. Res. 73:3-12.
8. Irvin, A. D., and E. R. Young. 1977. Possible in vitro test for screening drugs for activity against Babesia and other blood protozoa. Nature (London) 169: 407-409.
9. Irvin, A. D., and E. R. Young. 1979. Further studies on the uptake of tritiated nucleic acid precursors by Babesia spp. of cattle and mice. Int. J. Parasitol. 9: 109-112.
10. Jadin, J. B., and P. Giroult. 1981. Babesiosis and rickettsiosis, p. 132-135. In Society of Protozoologists (ed.), Parasitological topics special publication no. 1. Society of Protozoologists, Lawrence, Kans.
11. Mallick, K. P., S. K. Dwivedi, and N. K. Srivastana. 1987. A report on the occurrence of hemoprotozoan infections in rural livestock. Indiana J. Parasitol. 11:25-26.
12. Nott, S. E., W. J. O'Sullivan, A. M. Gero, and A. S. Bagnara. 1990. Routine screening for potential babesicides using cultures of Babesia bovis. Int J. Parasitol. 20:797-802.
13. Pudney, M., and J. S. Gray. 1997. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. J. Parasitol. 83:307-310.
14. Rabinovich, S. A., Z. K. Voronina, and N. I. Stepanova. 1978. Première découverte de babésiose humaine en URSS; courte analyse des cas décrits dans la littérature. Mosk. Med. Parasitol. 47:97-107.
15. Rodriguez, R. I., and A. J. Trees. 1996. In vitro responsiveness of Babesia bovis to imidocarb dipropionate and the selection of a drug-adapted line. Vet. Parasitol. 62:35-41.
16. Ruebush, T. K., R. H. Rubin, E. R. Wolpw, P. B. Cassaday, and M. G. Schultz. 1979. Neurologie complications following treatment of human Babesia microti infection with dimidazene aceturate. American J. Med. Hyg. 28:184-189.
17. Telford, S. R., A. Gorenflot, P. Brasseur, and A. Spielman. 1992. Babesial infections in humans and wildlife, p. 17. In J. P. Kreier (ed.), Parasitic protozoa. Academic Press, Inc., New York, N.Y.